Do not mix separate-vial peptides in one syringe they have different stability and pH requirements
They differ in mobility but also in structure: there are fibrous, synovial and cartilaginous joints
The best evidence available is that BPC-157 results in improved outcomes in muscle, tendon, ligament, and bone injury models in animals. There are probably trials ongoing, but if we are being honest about the totality of evidence available to us right now , it is irresponsible to claim either way that BPC-157 does or does not increase performance
Neurological Disorders Emerging research indicates that L-Carnitine may have therapeutic potential in various neurological disorders
Nature 609 , 761771 (2022)
Lin HV, Frassetto A, Kowalik Jr EJ, Nawrocki AR, Lu MM, Kosinski JR, et al